8-K: Abpro Holdings Amends Convertible Promissory Note with YA II PN, LTD to Correct Scrivener's Error

Abpro Holdings, Inc. amended its Convertible Promissory Note with YA II PN, LTD to correct a scrivener's error in the definition of the Conversion Price.

Summary

• Abpro Holdings, Inc. (Abpro) has amended its Convertible Promissory Note with YA II PN, LTD (Yorkville) on April 20, 2025.
• The amendment corrects a scrivener's error in the definition of the Conversion Price within the original Yorkville Note.
• The original Yorkville Note, for $3,000,000, was entered into on November 13, 2024, with net proceeds to Abpro of $2,755,000.
• The amended Conversion Price is the lower of $11.50 per Common Share (the Fixed Price) or 94% of the lowest daily VWAP during the 5 consecutive Trading Days immediately preceding the Conversion Date (the Variable Price), but the Variable Price shall not be lower than the Floor Price then in effect.
• The Fixed Price may be adjusted downwards if the VWAP of the Common Shares over the three Trading Days immediately preceding the 20th Trading Day following the Issuance Date is lower than the initial Fixed Price.
• All other terms of the Yorkville Note remain unchanged.

Sentiment

Score: 7

Explanation: The document is neutral to slightly positive. It addresses a technical correction in a financing agreement, which is generally a routine matter. However, the underlying reliance on convertible debt suggests some financial pressure.

Positives

• The amendment clarifies the terms of the convertible note, potentially reducing ambiguity and future disputes.
• The correction of the scrivener's error ensures the agreement reflects the intended terms.

Risks

• The company is reliant on funding from convertible notes, which can be dilutive to existing shareholders upon conversion.
• The variable conversion price, while subject to a floor, could result in significant dilution if the stock price declines substantially.

Future Outlook

The document does not contain specific forward-looking statements beyond the ongoing terms of the amended convertible note.

Industry Context

Convertible notes are a common financing tool for companies, particularly smaller ones, to raise capital. The amendment suggests a need to refine the terms of such agreements, which is not uncommon.

Comparison to Industry Standards

• Convertible notes are frequently used in the biotech industry, especially by companies in early stages of development.
• The specific terms, such as the conversion price and VWAP calculations, are deal-specific and depend on the negotiating power of the parties involved.
• Similar financing structures can be seen with companies like Mustang Bio and Celularity, which have also utilized convertible notes to fund operations and research.

Stakeholder Impact

• Shareholders may experience dilution upon conversion of the note.
• The amendment aims to clarify terms, potentially reducing future uncertainty for all stakeholders.

Key Dates

Keywords

Convertible Promissory Note, Amendment, Conversion Price, YA II PN, LTD, Yorkville, Abpro Holdings, Financing, VWAP